123 related articles for article (PubMed ID: 12426834)
1. Combined radiochemotherapy with paclitaxel in the treatment of malignant glioma.
Schuck A; Müller SB; Köhler A; Könemann S; Wienstroer M; Mosler C; Rübe CE; Wassmann H; Willich N; Rübe C
Strahlenther Onkol; 2002 Sep; 178(9):486-90. PubMed ID: 12426834
[TBL] [Abstract][Full Text] [Related]
2. Phase II study of paclitaxel in patients with recurrent malignant glioma.
Prados MD; Schold SC; Spence AM; Berger MS; McAllister LD; Mehta MP; Gilbert MR; Fulton D; Kuhn J; Lamborn K; Rector DJ; Chang SM
J Clin Oncol; 1996 Aug; 14(8):2316-21. PubMed ID: 8708723
[TBL] [Abstract][Full Text] [Related]
3. Radiosensitization of malignant gliomas following intracranial delivery of paclitaxel biodegradable polymer microspheres.
Gabikian P; Tyler BM; Zhang I; Li KW; Brem H; Walter KA
J Neurosurg; 2014 May; 120(5):1078-85. PubMed ID: 24605841
[TBL] [Abstract][Full Text] [Related]
4. Simultaneous paclitaxel and radiotherapy: initial clinical experience in lung cancer and other malignancies.
Vogt HG; Martin T; Kolotas C; Schneider L; Strassmann G; Zamboglou N
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-101-S12-105. PubMed ID: 9331131
[TBL] [Abstract][Full Text] [Related]
5. Aggressive simultaneous radiochemotherapy with cisplatin and paclitaxel in combination with accelerated hyperfractionated radiotherapy in locally advanced head and neck tumors. Results of a phase I-II trial.
Kuhnt T; Becker A; Pigorsch S; Pelz T; Bloching M; Passmann M; Lotterer E; Hänsgen G; Dunst J
Strahlenther Onkol; 2003 Oct; 179(10):673-81. PubMed ID: 14566475
[TBL] [Abstract][Full Text] [Related]
6. Combined-modality therapy for advanced non-small cell lung cancer: paclitaxel and thoracic irradiation.
Choy H; Yee L; Cole BF
Semin Oncol; 1995 Dec; 22(6 Suppl 15):38-44. PubMed ID: 8643969
[TBL] [Abstract][Full Text] [Related]
7. 3D conformal radiotherapy and cisplatin for recurrent malignant glioma.
VanderSpek L; Fisher B; Bauman G; Macdonald D
Can J Neurol Sci; 2008 Mar; 35(1):57-64. PubMed ID: 18380278
[TBL] [Abstract][Full Text] [Related]
8. Simultaneous radiochemotherapy with paclitaxel in non-small cell lung cancer: a clinical phase I study.
Vogt HG; Kolotas C; Martin T; Schneider LV; Neeb A; Mitrou PS; Diergarten K; Dornoff W; Zamboglou N
Semin Oncol; 1996 Dec; 23(6 Suppl 15):26-30. PubMed ID: 8996594
[TBL] [Abstract][Full Text] [Related]
9. Concurrent chemoradiotherapy with weekly paclitaxel in malignant cerebral glioma treatment.
Montemor JP; Peria FM; Monti CR; Petrilli LS; Colli BO; Carlotti Júnior CG
Onkologie; 2008 Sep; 31(8-9):435-9. PubMed ID: 18787350
[TBL] [Abstract][Full Text] [Related]
10. Fractionated stereotactic radiotherapy boost and weekly paclitaxel in malignant gliomas clinical and pharmacokinetics results.
Ashamalla H; Zaki B; Mokhtar B; Lewis L; Lavaf A; Nasr H; Colella F; Dosik D; Krishnamurthy M; Saad N; Guriguis A
Technol Cancer Res Treat; 2007 Jun; 6(3):169-76. PubMed ID: 17535024
[TBL] [Abstract][Full Text] [Related]
11. Twice-weekly paclitaxel and radiation for stage III non-small cell lung cancer.
Lau DH; Ryu JK; Gandara DR; Morgan R; Doroshow J; Wilder R; Leigh B
Semin Oncol; 1997 Aug; 24(4 Suppl 12):S12-106-S12-109. PubMed ID: 9331132
[TBL] [Abstract][Full Text] [Related]
12. Paclitaxel for the treatment of progressive or recurrent childhood brain tumors: a pediatric oncology phase II study.
Hurwitz CA; Strauss LC; Kepner J; Kretschmar C; Harris MB; Friedman H; Kun L; Kadota R
J Pediatr Hematol Oncol; 2001; 23(5):277-81. PubMed ID: 11464982
[TBL] [Abstract][Full Text] [Related]
13. Concurrent twice-a-week docetaxel and radiotherapy: a dose escalation trial with immunological toxicity evaluation.
Koukourakis MI; Giatromanolaki A; Schiza S; Kakolyris S; Georgoulias V
Int J Radiat Oncol Biol Phys; 1999 Jan; 43(1):107-14. PubMed ID: 9989521
[TBL] [Abstract][Full Text] [Related]
14. Paclitaxel and radiotherapy in the treatment of advanced non-small cell lung cancer.
Marangolo M; Emiliani E; Rosti G; Giannini M; Vertogen B; Zumaglini F
Semin Oncol; 1996 Dec; 23(6 Suppl 15):31-4. PubMed ID: 8996595
[TBL] [Abstract][Full Text] [Related]
15. Paclitaxel and concurrent radiation therapy for locally advanced adenocarcinomas of the pancreas, stomach, and gastroesophageal junction.
Safran H; Akerman P; Cioffi W; Gaissert H; Joseph P; King T; Hesketh PJ; Wanebo H
Semin Radiat Oncol; 1999 Apr; 9(2 Suppl 1):53-7. PubMed ID: 10210540
[TBL] [Abstract][Full Text] [Related]
16. A phase I study of cranial radiation therapy with concomitant continuous infusion paclitaxel in children with brain tumors.
Liu L; Vapiwala N; Munoz LK; Winick NJ; Weitman S; Strauss LC; Frankel LS; Rosenthal DI
Med Pediatr Oncol; 2001 Oct; 37(4):390-2. PubMed ID: 11568904
[TBL] [Abstract][Full Text] [Related]
17. Preirradiation paclitaxel in glioblastoma multiforme: efficacy, pharmacology, and drug interactions. New Approaches to Brain Tumor Therapy Central Nervous System Consortium.
Fetell MR; Grossman SA; Fisher JD; Erlanger B; Rowinsky E; Stockel J; Piantadosi S
J Clin Oncol; 1997 Sep; 15(9):3121-8. PubMed ID: 9294475
[TBL] [Abstract][Full Text] [Related]
18. Radiation and concomitant weekly administration of paclitaxel in patients with glioblastoma multiforme. A phase II study.
Fountzilas G; Karavelis A; Capizzello A; Kalogera-Fountzila A; Karkavelas G; Zamboglou N; Selviaridis P; Foroglou G; Tourkantonis A
J Neurooncol; 1999; 45(2):159-65. PubMed ID: 10778731
[TBL] [Abstract][Full Text] [Related]
19. Influence of bromodeoxyuridine radiosensitization on malignant glioma patient survival: a retrospective comparison of survival data from the Northern California Oncology Group (NCOG) and Radiation Therapy Oncology Group trials (RTOG) for glioblastoma multiforme and anaplastic astrocytoma.
Prados MD; Scott CB; Rotman M; Rubin P; Murray K; Sause W; Asbell S; Comis R; Curran W; Nelson J; Davis RL; Levin VA; Lamborn K; Phillips TL
Int J Radiat Oncol Biol Phys; 1998 Feb; 40(3):653-9. PubMed ID: 9486616
[TBL] [Abstract][Full Text] [Related]
20. [Radiotherapy of malignant brain gliomas using teniposide].
Mufazalov FF; Sakaeva DD; Shtefan AIu
Vopr Onkol; 2008; 54(2):208-10. PubMed ID: 18522171
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
